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Caged photolysable compounds have served to be pivotal to neuroscientific investigations; 
allowing the cognizing of molecular kinetics and properties of neuronal micro-machinery such as 
neurotransmitter receptors. Precision in terms of temporal and spatial resolution of 
neurotransmitter release endowed by photolysis has multitudinal applicabilities in the realm of 
GABAA receptors (GABAARs), their neuronal niche and effects on neuronal and network activity. 
Caged compounds, in their caged form, may display certain unideal traits such as undesired 
interactions with the system and antagonistic activity on the target receptor. This study aims to 
reevaluate the GABAAR antagonistic actions of caged Rubi-GABA, which was found to 
antagonize these receptors at significantly lower concentrations than those reported in the 
literature. Furthermore, this study electrophysiologically characterizes the possible antagonistic 
properties of a novel quinoline-derived UV-photolysable caged GABA compound, 
8-DMAQ-GABA, whose activity, in its caged form appears to have a much more favorable 
antagonism profile compared to the widely used RuBi-GABA. To assess the antagonistic effects 
of these compounds on GABAAR-mediated miniature inhibitory postsynaptic currents (mIPSCs) 
patch-clamp recordings were carried out in the whole-cell voltage clamp configuration on cortical 
layer 2/3 cortical pyramidal neurons in acute neocortical slices prepared from 16-18 day-old rat 
rats. The results of this study indicate a revised antagonism profile for caged Rubi-GABA, with 
marked GABAAR toxicity in the low micromolar range. The study also scrutinizes the photo-
kinetic properties of both caged GABA compounds and reveals that the rate of GABA release from 
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2.1 Caged compounds  
A vast assemblage of diverse compounds stratified as “caged compounds” are essentially 
photosensitive molecular tools, comprising of a biologically active molecule or particles, that have 
been rendered inert by a sheathing cage group (Furuta & Noguchi, 2004; (Adams & Tsien, 1993). 
The ensnared bio-active component of this conjugate is liberated upon illumination, thus 
facilitating intended interference with cellular processes and cascades; steered specifically and 
with precision(Ellis-Davies, 2007)(Furuta & Noguchi, 2004). These photo-chemically propelled 
molecular apparatuses have been described as complemental to, yet, well demarcated from optical 
methods such as fluorescence microscopy, as these optical techniques serve discrete purposes. 
Caged compounds confer control of cellular processes while fluorescence microscopy serves as 
an observational tool for intracellular morphology and mechanisms(Ellis-Davies, 2007). 
It is pertinent to emphasize that the term “caging”, (Jack H. Kaplan, Forbush, & Hoffman, 1978), 
is used merely for the ease of description and not for its accuracy in this context (Adams & Tsien, 
1993). Though scientific methods have indeed enabled encapsulation of a molecule in its entirety 
by another(Cram, 1992)(Fagan, Calabrese, & Malone, 1992); disintegration of these shells via 
photolysis is extremely arduous if not unfeasible. Hence, the fundamental edifice of all efficacious 
caged compounds is held together simply by a covalent bond that veils an essential facet implicated 
in the compound’s recognition by the biological system. The consequent breakage of that 
particular bond results in the discharge of the biologically active chemical(Adams & Tsien, 1993). 
From ions to massive bio macromolecules, practically all classes of signaling entities have been 
rendered into caged compounds (Mayer & Heckel, 2006)(Ellis-Davies, 2007). When employed in 
concert with other investigative methods such as genetics or electrophysiology, manipulation via 
photons allows experimental manipulation a specific cellular target with high temporal and spatial 
resolution (Mayer & Heckel, 2006). Photolytic caged compounds are useful in biological 
investigations as a light source can be finely tuned spatially and, temporally, thus endowing the 
ability to alter concentration of the given bio-active chemical in an instantaneous and specified 
manner (Adams & Tsien, 1993).  
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The capacity of manipulation via caged compounds is especially pivotal in cases where mechanical 
interferences are unfeasible, such as in the case of an integral cellular entity or tissue; or when 
spatial gradients of miniscule nature are necessitated (Adams & Tsien, 1993). Furthermore, since 
photons are able to traverse membranes and membranal compartments, active molecules can be 
precipitously liberated and conveyed to intracellular regions via uncaging. This is not achievable 
via extracellular application of second messengers such as ATP, IP3 cAMP and calcium ions for 
instance, as these charged entities are unable to penetrate the membrane (Ellis-Davies, 2007).   
Photolytic intervention via caged compounds is a useful method for investigation of rapid kinetics 
and spatial disparities of biochemical processes (Adams & Tsien, 1993). Confined illumination of 
the beam can be used to specifically alter biochemistry of the cell in one region, and alternatively, 
a global light source liberates the species throughout the cell. It is also possible to alter extracellular 
biochemistry, thereby influencing a population of cells synchronously, to monitor network 
dynamics (Mayer & Heckel, 2006)(Ellis-Davies, 2007). Thus, due to their diverse applications, 
the use of photo-active compounds has become preponderant in numerous arenas of biology, 
especially in neuroscience, in the recent decades (Jerome & Heck, 2011). 
Caged species 
Significant caged second messengers and caged bio active chemicals include caged ions, notably 
caged calcium (Tsien & Zucker, 1986) (Adams, Kao, Grynkiewicz, Minta, & Tsien, 1988) (Ellis-
Davies, 1998), caged inositols (J W Walker, Feeney, & Trentham, 1989); caged nucleic acids 
(DNA and mRNA) (J H Kaplan, Forbush, & Hoffman, 1978)(Jeffery W. Walker, Reid, McCray, 
& Trentham, 1988) (Monroe, McQuain, Chang, Alexander, & Haselton, 1999) (Ando, Furuta, 
Tsien, & Okamoto, 2001); and even caged macromolecules such as peptides and enzymes (Ghosh 
et al., 2004)(Mendel, Ellman, & Schultz, 1991)(Rothman et al., 2005)(Jeffery W. Walker et al., 
1998); and caged neurotransmitters (Bartels, Wassermann, & Erlanger, 1971)(Wieboldt et al., 
1994a)(J W Walker, McCray, & Hess, 1986a)(M Matsuzaki et al., 2001)(A. M. Gurney & Lester, 
1987). 
2.2 Optical electrophysiology  
The field of optical electrophysiology and its expansive milieu employs energy in the form of light 
to probe the cellular, neuronal, genetic and molecular machinery, thereby influencing and 
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comprehending their function. Caged neurotransmitters, optogenetic techniques and voltage-
sensitive dyes are currently the most persuasive methods in this context, offering discrete facilities 
to study and control neural systems. Here, these photochemically delineated techniques will be 
briefly overviewed to thereby demarcate the applicability of caged neurotransmitters. 
Caged neurotransmitters 
Specifically in the field of electrophysiology, caged neurotransmitters impart the experimenter the 
ability to stimulate and perturb neuronal activity devoid of electrodes, among other mechanically 
invasive probes (Shi, Trigo, Semmelhack, & Wang, 2014b). This offers the possibility of 
interfering with the activity of singular neurons to more global contexts such as circuits and neural 
networks. Upon application to intact neuronal tissues and brain slices, these compounds activate 
discrete transmitter networks and pathways with high spatiotemporal resolution and control down 
to micrometer and millisecond scales (Furuta & Noguchi, 2004). As explained earlier, as all caged 
molecules, photolabile neurotransmitters are essentially neurotransmitters conjugated with a 
photolytic sheathing cage group. In its caged form the neurotransmitter is inactive and is not able 
to modulate its target receptor in a fashion it normally would without the cage. With suitable 
illumination, the covalent bond is broken, liberating the neurotransmitter and allowing it to bind 
its receptor and exert its usual functions (Adams & Tsien, 1993).  
Using caged neurotransmitter molecules, methodical and periodic light activation is achievable, 
controlling multiple neuronal sites synchronously (Shoham, O’Connor, Sarkisov, & Wang, 
2005)(Katz & Dalva, 1994). This is not feasible with a comparable degree of control or precision 
when using microelectrode techniques(Shi et al., 2014b).  
Photo-labile caged neurotransmitters are an expedient substitute to methods that require genetic 
alterations and interferences such as optogenetics. This is because caged molecules do not 
necessitate any form of recombination, genetic targeting or delivery—thus leaving the system 
genetically unperturbed and in its intrinsic state. This means there are no off target gene alterations, 
and laborious gene work related breeding/culturing is circumvented. Furthermore, in comparison 
to other photo-stimulatory methods, there is a good degree of freedom with respect to the 
parameters such as wavelengths of light sources used in uncaging techniques (Shi et al., 2014b).  
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Optogenetics 
Amalgamating technologies of optical and genetic nature, optogenetics is a photostimulatory 
method that enables manipulation of distinct and demarcated cellular functions (Deisseroth, 2011). 
Neuronal cells and other cellular entities may be genetically altered and made to express photo-
sensitive elements such as receptors or ion channels (Deubner, Coulon, & Diester, 2019). The 
methods confer modulatory control over cellular functions and capacity to monitor biological 
phenomena in real time, and in live systems. These techniques may be employed in vitro and in 
vivo, propounding an extensive range of prospects to understand neuronal, genetic and cellular 
mechanisms in conjunction with behavioral manifestations. The effects of the photostimulatory 
events, from biological to behavioral contexts, may be observed and computed in instantaneously 
(Deisseroth, 2011). The principal players of this method are photosensitive peptides and protein 
macromolecules that exert their functions in response to encountering light (Mancuso et al., 
2011)(Pastrana, 2011)(Fenno, Yizhar, & Deisseroth, 2011).  
In the neuroscientific paradigms, optogenetic tools are frequently categorized into one of the two 
classes of “actuators” and “sensors” (Mancuso et al., 2011). Implementing optogenetic actuator 
proteins permits alteration of neuronal activity by triggering or inhibiting their firing. High 
spatiotemporal regulation and resolution is a concomitant feature of this technique; and 
photosensitive actuators may be genetically incorporated to distinct neuronal types and networks. 
Interference and regulation of neuronal activity is conferred by employing proteins such as 
channelrhodopsins and halorhodopsins (Mancuso et al., 2011). The other class of optogenetic 
proteins are the sensors, who are necessitated in the process of mapping neuronal networks and 
cellular activity. These proteins are essentially altered genetically so their photophysical attributes 
are modified in concursion with neural functions. They are employed to distinguish minute events 
and alterations of the membrane voltage, and also bigger events such are action potential firing 
(Pastrana, 2011). 
Despite serving as powerful apparatuses for manipulating and computing neuronal events, there 
are several predicaments associated with optogenetic tools (Packer, Roska, & Häusser, 
2013)(Mancuso et al., 2011). Some of these issues include unspecific and inaccurate targeting of 
neuronal populations and inaccuracies with respect to numerical and spatial control of neuronal 
manipulation (Packer et al., 2013). Furthermore, there is also a marked degree of inconsistency in 
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the extent to which a group of cells are optogenetically modulated, in given a site of neural tissue. 
These issues in essence reflect erroneous targeting, from unpredictable and imprecise expression 
of optically modified genes to the overall photophysical scope of manipulating (Packer et al., 
2013)(Mancuso et al., 2011). 
Voltage sensitive dyes 
Voltage sensitive dyes are comparable to optogenetic sensors in their functions; they are essentially 
potentiometric dyes that alter their optical properties as a consequence of fluctuations or variations 
in the membrane potential (Cohen & Salzberg, 1978)(Antic, Empson, & Knöpfel, 2016)(Miller, 
2016). They possess a range of applications, from the quantification of action potentials elicited 
by distinct neuronal cells, to activity seen in vast neuronal networks. They are also used to study 
the electrical activity of non-neuronal cells such as muscle and cardiac cells (Miller, 2016)(Herron, 
Lee, & Jalife, 2012).  
Potentiometric dyes are employed to distinguish or ascertain the location where an action potential 
is initiated; and kinetic parameters, such as rate, velocity and course, concomitant to neuronal 
firing may be computed, elucidating morphological information about neurons (Baker et al., 
2005)(Antic et al., 2016)(Cohen & Salzberg, 1978). They can be employed to synchronously 
monitor the activity of numerous locations, to comprehend networks (Baker et al., 2005). Their 
application is especially pertinent when electrophysiological techniques necessitating electrodes 
is not feasible to measure and scrutinize activity within a cell. They can be used even to detect 
membrane potential changes within cellular organelles, such as the mitochondria (Perry, Norman, 
Barbieri, Brown, & Gelbard, 2011), and fine neuronal structures such as dendritic spines (Popovic, 
Carnevale, Rozsa, & Zecevic, 2015), where traditional microelectrodes cannot be used. Studies 
have even demonstrated their applications in vivo, allowing scrutiny and quantification of neuronal 
activity in live animals (Ferezou, Matyas, & Petersen, 2009) permitting real time assessments, 
conjugating behavioural phenomena with encephalic functions. 
Regardless of their vast applications, these optical apparatuses are associated with certain 
limitations. In in vitro studies, potentiometric dyes appear to display inconsistency with respect to 
how they perform in different experiments (Baker et al., 2005). They also exhibit inadequacies 
with respect to properly permeating samples, especially in regions with connective tissue. Thus, 
proper staining is not achieved, and is accompanied by several predicaments (Preuss & Stein, 
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2013). Additionally, undesired, off target effects may be elicited due to the pharmacological 
attributes of the dyes, instigating perpetual effects on neuronal cells subjected to staining (Preuss 
& Stein, 2013). Other concomitant predicaments include poor signal to noise ratio, photobleaching 
and inadequate staining intensity (Preuss & Stein, 2013)(Baker et al., 2005). In in vivo studies, 
voltage-sensitive dyes have also displayed deficiencies—such as small amplitudes, lack of 
specificity with respect to staining membranes, restrained permeation within certain cortical layers, 
and inability to distinguish between different types of neuronal populations (Ferezou et al., 
2009)(Canepari, Willadt, Zecevic, & Vogt, 2010)(Chemla & Chavane, 2009).  
Thus, the varying forms of photo-stimulatory and optical electrophysiological methods have 
intrinsic benefits and limitations, as briefly addressed by this section. Employment of these 
techniques for neuroscientific investigations is based on choices delineated by their inherent 
attributes, the limitations they levy, the query that is being pursued and the pertinent experimental 
model (Kramer, Fortin, & Trauner, 2009). Having illustrated a background of comparable 
techniques, I will now focus on elucidating the properties of photoactivatable caged 
neurotransmitters and their applications.   
 
2.3 Photoactivatable neurotransmitters  
 
Photoactivatable caged neurotransmitters have been a robust tool to comprehend neural function. 
The caged precursor molecule liberates the neurotransmitter upon illumination, following the 
disintegration of the covalent bond (Ellis-Davies, 2007)(Kramer et al., 2009)(Adams & Tsien, 
1993). In the neuroscientific paradigms, neurotransmitters and neurotransmitter receptor agonists 
have been the most preponderantly used photoactivatable molecules (Kramer et al., 2009). Their 
spatiotemporal resolution with respect to altering neurotransmitter, agonist, and antagonist levels 
elicited by illumination offers numerous facilities to scrutinize and explicate kinetic, structural, 
pharmacological and mechanical properties of neuronal molecular machinery (Mayer & Heckel, 
2006). 
The first transmitter receptor agonists to be employed in caging techniques were UV-sensitive o-
nitrobenzyl carbomoylcholine molecules. They were pivotal in the comprehending kinetic 
properties of acetylcholine receptors and neuronal activation mechanisms (Milburn et al., 1989)(J 
W Walker, McCray, & Hess, 1986b)(Kramer et al., 2009). Caged glutamate however, was the first 
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truly effective caged neurotransmitter and still persists as the most extensively used (Wieboldt et 
al., 1994b)(Kramer et al., 2009)(Ellis-Davies, 2007). Notably, glutamate uncaging led to discovery 
of visual cortex network and synaptic alterations over the course of neurodevelopment (Dalva & 
Katz, 1994). Currently, various forms of photolabile caged glutamate exist and have been 
formulated using different caging tactics (Ellis-Davies, 2007).  
The caged photolabile counterparts of various neurotransmitters and neuroactive agents have been 
produced including single photon and two photon-sensitive varieties of photolabile GABA, 
glycine, dopamine, serotonin, anandamides and endocannabinoid receptor agonists (Mayer & 
Heckel, 2006)(Ellis-Davies, 2007)(Rial Verde, Zayat, Etchenique, & Yuste, 2008)(Heinbockel et 
al., 2005)(Shembekar, Chen, Carpenter, & Hess, 2007)(Kramer et al., 2009). Furthermore, caging 
has been employed with receptor antagonists, such as a photolabile azide conjugated AMPA 
receptor antagonist ANQX, which, notably, illumined AMPA receptor trafficking rates during 
LTP (Adesnik, Nicoll, & England, 2005). 
Ideal traits of caged neurotransmitters 
To be efficaciously employed in research of biological nature, caged photolabile compounds such 
as neurotransmitters must fulfill several requisites. The caging conjugate must make the bioactive 
neurotransmitter completely inert when in the caged form. The caged compound needs to be 
sufficiently soluble in solutions of aqueous nature and must be stable in physiological conditions, 
temperatures and pH. The cage molecule or products following photolysis should not pose toxic 
effects in the cell, and must not elicit any off-target effect or interferences with the cellular 
mechanisms, except for the intended effect of the uncaged neurotransmitter. With respect to the 
photolysis reaction, the products must be generated with high quantum yield, and the reaction must 
take place at an adequate velocity. Thus, both the quantum yield (ceiling limit of quantity of 
neurotransmitter liberated) and rate of photolysis (velocity of reaction) must be quantifiable and 
useful. Kinetics of cellular and molecular response events can be appreciated only if the photolysis 
reaction is rapid compared to the investigated mechanism (J H Kaplan & Somlyo, 1989).(Mayer 
& Heckel, 2006)(Adams & Tsien, 1993)(Ellis-Davies, 2007)(Kramer et al., 2009)(Hess, Lewis, & 
Chen, 2014)(Lester & Nerbonne, 1982).  
Light eliciting the photolysis must pose minimal phototoxicity; and hence wavelengths not shorter 
than long-wave UV, which has sufficiently low photon energy, are are used.  Control experiments 
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must be performed to ensure that the flash itself, independent of the caged neurotransmitter does 
not actuate a response. Stability of the caged compound and consequent photolytic products is 
crucial; so there is indeed a veritable concentration elevation of the neurotransmitter following the 
triggered light source (Mayer & Heckel, 2006)(Adams & Tsien, 1993)(Ellis-Davies, 
2007)(Kramer et al., 2009)(Hess et al., 2014)(Lester & Nerbonne, 1982)(J H Kaplan & Somlyo, 
1989). 
2.3.1 Advantages  
The use of caged photoactivatable neurotransmitters has several intrinsic benefits in comparison 
to alternative techniques for modifying intra and extra-neuronal concentrations of 
neurotransmitters. Their use enables tremendously quick intracellular release with high 
spatiotemporal resolution and reproducibility (Ellis-Davies, 2007). 
Temporal resolution 
Neurotransmitter release as a consequence of photolysis of the caged antecedent molecule is 
usually more rapid in comparison to other methods such as rapid perfusion change and pressurized 
application of the neurotransmitter by ‘puffing’ or ‘spritzing’. In the former case a lag is certainly 
present as the solution with no bioactive molecules needs to be replaced with a solution with the 
bioactive constituents. Pressurized application is not devoid of lag due to diffusion of the 
neurotransmitter to its cognate receptor. The employment of photoactivatable compounds 
circumvents these predicaments by placing the caged transmitter in close proximity to the receptor 
(Ellis-Davies, 2007).  
Spatial resolution 
A primary potent feature of photoactivatable neurotransmitter release is that it is specific to the 
location of illumination, with minimal spot size being limited by diffraction. Caged compounds 
can be profusely present in the cytoplasm of neurons and photolysis can be specified by choosing 
between illuminating globally or at precise intracellular compartments (Ellis-Davies, 2007)(Rial 
Verde et al., 2008), a feature not often within the scope of other manipulative methods such as 
puffing and iontophoresis whose spatial resolution is not comparable (Rial Verde et al., 2008). 
Juxtaposing uncaging with alternative approaches  
Various methods have been employed to scrutinize and comprehend neurotransmitter and synaptic 
mechanisms such as stimulation with electrodes (Connors, Malenka, & Silva, 1988) (Alger & 
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Nicoll, 1979), application of neurotransmitters via iontophoresis (Andersen, Dingledine, Gjerstad, 
Langmoen, & Laursen, 1980), puffing (Feng, Tang, Chen, & Yang, 2017), and pressure injection 
(Connors et al., 1988). These aforementioned methods while holding their applications, also 
display several restrictions. Stimulating with electrodes has been critised for being a method with 
poor yield, and localization of receptors is not feasible with this method. Iontophoresis on the other 
hand may offer spatiotemporal regulation but this is limited. It is also a very invasive method and 
hence unfavorable for repeated or continuous investigation of a single neuron or local network 
(Rial Verde et al., 2008). Optogenetics, which offers comparable spatiotemporal resolution 
jeopardizes the genetic integrity of the tissue—and genetic alterations make the intrinsic attributes 
of the preparation questionable (Malyshev, Goz, LoTurco, & Volgushev, 2015).  
Methods such as exchanging solution, rapid profusion and puffing though permitting transmitter 
application, do not evoke swift responses nor access to intra-neuronal sites. They also offer 
inadequate spatiotemporal control (Amatrudo, Olson, Agarwal, & Ellis-Davies, 2015). 
Photoactivatable neurotransmitters hence offer superior spatiotemporal release, and are non-
invasive, and do not necessitate genetic alterations – offering optimal control with minimal 
perturbation. 
 
2.3.2 Limitations  
 
A predominant number of erroneous methodologies related to caged neurotransmitters are 
primarily due to cellular or pharmacological interactions exhibited by the caged precursor or its 
non-target by-products; reactions triggered by the light source on its own, and the rate-limiting 
nature of the relatively slower dark reactions of photolysis, whose speed is specific to the 
chemistries of both the cage molecule and the molecule being caged (Gurney, 2008)(Kaplan & 
Somlyo, 1989). Therefore, it is crucial that the caged neurotransmitter is thoroughly evaluated, its 
parameters quantified and validated prior to its employment in biological research(Hess et al., 
2014). 
A notorious predicament associated with caged neurotransmitters is the antagonistic behavior of 
some caged compounds on target receptors when in the un-photolysed form (Masanori Matsuzaki, 
Hayama, Kasai, & Ellis-Davies, 2010a)(Rial Verde et al., 2008)(Molnár & Nadler, 
2000)(Amatrudo et al., 2015)(Shi, Trigo, Semmelhack, & Wang, 2014a) setting limitations on the 
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ceiling concentrations that may be used. This is often much lower than the true concentrations of 
neurotransmitters present in the cleft during synaptic neurotransmission(Shi et al., 2014a). 
Studies have illumined that the caged precursor also has several off-target and undesired 
interactions with the cellular and neuronal systems(Adams & Tsien, 1993)(A. Gurney, 2008). 
Certain photoactivatable compounds also appear to display activity in target receptors even prior 
to illumination. Effects of photolysed by-products on cellular processes is also a concomitant 
issue(A. Gurney, 2008).  
2.4. Brief glance at GABA receptors in the CNS  
 
Gamma-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the supraspinal 
CNS the adult CNS, GABA exerts its inhibitory function by diminishing neuronal excitability. 
The receptor targets of this neurotransmitter are ligand-gated ion channel GABAA receptors 
(GABAARs) and metabotropic GABAB receptors (GABABRs), in the synaptic, extra synaptic and 
presynaptic forms (Kaila, 1994)(Buzsáki, Kaila, & Raichle, 2007)(Farrant & Nusser, 
2005)(Watanabe, Maemura, Kanbara, Tamayama, & Hayasaki, 2002a)(Farrant & Kaila, 2007). 
The fundamental subunit constitution determines their molecular edifice, isoform; and 
consequently their functions and affinities to GABA.  
 
2.4.1 GABAA receptors  
 
Under physiological conditions GABAARs are permeable to chloride and to a lesser extent 
bicarbonate ions (Kaila & Voipio, 1987)(Kaila, 1994)(Farrant & Nusser, 2005). In most mature 
neuron, with low intracellular chloride concentrations, GABAAR activation mediates inward flow 
of negative ions and an inhibitory post synaptic response. The electrochemical potential gradient 
across the neuronal membrane for chloride, is set by secondary-active chloride transporters, and 
ultimately determines the action on the membrane voltage of GABA binding to GABAARs. For 
instance secondary active uptake of chloride raising its concentration in the neuron enables 
GABAARs to mediate depolarizing currents as chloride ions are expelled down what is now an 
outward electrochemical gradient. Under such  circumstances, GABA may function as an 
excitatory transmitter, as seen in some adult neuronal populations and more typically in immature 
neurons (Farrant & Kaila, 2007)(W Sieghart, 1995)(Watanabe, Maemura, Kanbara, Tamayama, 
& Hayasaki, 2002b)(Bureau et al., 1999)(Kai Kaila, Price, Payne, Puskarjov, & Voipio, 2014). 
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GABAARs are heteropentameric structures incorporating five subunits circumscribing a central 
ligand-gated, anion-permeant pore (Sigel & Steinmann, 2012). All isoforms of this class of 
receptors adhere to this structural blueprint and their subunit configuration determines their 
neuronal functions, location, attributes and pharmacological pertinence. 
The subunits of this receptors are stratified into several classes; presently 16 subunits including 
α1–6, β1–3, γ1–3, δ, ε, θ, π and 3 ρ subunits have been distinguished, cloned and sequenced from 
the mammalian encephalic systems (W Sieghart & Sperk, 2002). Moreover, several splice variants 
for certain subunits have been sequestered and examined (Barnard et al., 1998)(Simon, Wakimoto, 
Fujita, Lalande, & Barnard, 2004). The preponderant subunit composition of native receptors 
encompasses alpha, beta and gamma subunits (α, β, γ). In less predominant isoforms, delta (δ), 
epsilon (ε), and pi (π) subunits replace the gamma subunit, and theta (θ) subunit replaces the beta 
(Werner Sieghart, 2006).  
GABAARs distinguished both by subunits and neuronal niche mediate fast inhibition in discrete 
forms. They elicit fast inhibition in the millisecond time frame when sited synaptically; and long-
term, slow inhibition as a consequence of ambient GABA (tonic) when located peri- and extra-
synaptically (Farrant & Kaila, 2007)(Farrant & Nusser, 2005). 
GABAARs were primarily recognized pharmacologically by their agonistic activation by GABA, 
and selective agonist muscimol; their modulation by CNS depressant drug classes such as 
benzodiazepines, barbiturates, alcohol, and their obstruction by bicuculline and picrotoxin. These 
pharmacological agents exert their effect through binding with discrete allosteric sites on 
GABAARs (Macdonald & Olsen, 1994)(Smith & Olsen, 1995)(Scimemi, 2014).  
These inhibitory receptors are indispensable to CNS functions, playing pivotal roles in various 
phenomena ― from fundamentally regulating excitation, shaping CNS development to learning 
and memory (Davies, 2003; Scimemi, 2014)(Olsen & Avoli, 1997)(Möhler, 2012)(Pratt, 
1992)(Wagner, Castel, Gainer, & Yarom, 1997)(Izquierdo & Medina, 1991)(Berridge & Peciña, 
1995)(Sarter, Schneider, & Stephens, 1988)(Paulsen & Moser, 1998)(Farrant & Kaila, 2007). As 
a consequence of their preponderance in the CNS, this class of inhibitory receptors serve as 
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pharmacologically manipulated targets for a multitude of drugs in research and clinical domains 
(Hevers & Lüddens, 1998)(Szczot, Kisiel, Czyzewska, & Mozrzymas, 2014). 
2.4.1.1 Synaptic (phasic) GABAA receptors 
Fast GABAergic synaptic transmission is mediated by phasic GABAARs, whose subunit 
composition (in the mature neocortex most commonly α1β2γ2) enables them to facilitate synaptic 
shunting or voltage inhibition with high temporal precision (Kaila et al. 2014 CurrOpNeurobiol; 
Farrant and Nusser, 2005 NRN). Upon the advent of neuronal action potential firing in a 
GABAergic neuron, there is a localized influx of calcium ions which subsequently elicits the 
fusion of presynaptic neurotransmitter vesicles. This educes a discharge of thousands of GABA 
molecules into the synaptic cleft. They then diffuse and traverse the cleft and consequently bind 
synaptic GABAARs, eliciting a contemporaneous activation of ion pores. Membrane permeability 
for chloride and bicarbonate ions is thereby intensified (Farrant & Nusser, 2005). 
GABAARs located in the synapse sites of neurons orchestrate a form of inhibition referred to as 
phasic inhibition. They aspect pre-synapse neurotransmitter release sites and are consequently 
triggered by being ephemerally subjected to an elevated level of GABA liberated by exocytic 
vesicular elements (Farrant & Nusser, 2005).  In an extremely transitory timeframe of hundred 
microseconds, the GABA transmitter molecules are rapidly disseminated from the original site of 
liberation (Mozrzymas, Zarnowska, Pytel, Mercik, & Zarmowska, 2003). On the other hand they 
may be cleared via uptake by GABA transporters (Scimemi, 2014) such as GAT, and hence 
depleting the activation of the channels. This is principally phasic inhibition, concomitant with a 
tremendously transitory interval of GABAergic currents and its spatiotemporal facets highly tuned 
by vesicular liberation of the neurotransmitter GABA (Istvan Mody, 2001). 
With respect to synaptic cleft concentrations of GABA, even a singular synaptic vesicle fusing 
unfetters up to thousands of neurotransmitter molecules in a 20nm wide cleft (Farrant & Kaila, 
2007), eliciting ceiling concentrations of millimolar GABA (Mody, De Koninck, Otis, & Soltesz, 
1994)(Mozrzymas, 2004)(Mozrzymas et al., 2003). 
Hence, an elevated concentration of neurotransmitter is a pivotal to phasic receptors and the 
timeframe of the persisting transmitter is crucial to molding the currents. Studies have unveiled 
Page | 17 
 
the peak GABAergic phasic concentration to be around 3-5mM, which is dispelled in the 
timeframe of 300 to 500 microseconds (Cherubini, 2012).  
2.4.1.2 Extrasynaptic (tonic) GABAA receptors  
Extrasynaptic, high-affinity GABAARs (with a subunit composition consisting of α5βγ2, α4βγ2 or 
α1βδ) orchestrate a tonic form of inhibition (Kaila, Ruusuvuori, Seja, Voipio, Puskarjov, 2014). 
They are sited away from synaptic regions and perpetually subjected to exposure of ambient nano-
micromolar concentrations of GABA (Wu et al., 2013)(Farrant & Kaila, 2007)(Farrant & Nusser, 
2005). Tonic forms of inhibition, contrariwise to the precipitous phasic inhibition, are 
spatiotemporally disconnected from presynaptic GABAergic liberation. Tonic inhibition is 
characterized by a perpetual and tenacious chloride conductance indicating steady state 
extrasynaptic GABAA receptor activation(Farrant & Nusser, 2005). The fundament of this 
“paracrine” activation is the profuse localization of GABAA receptors in the neuronal membranes 
of somatic, dendritic and axonal regions that are distally sited from the original location of 
neurotransmitter release(Kullmann et al., 2005a)(Semyanov, Walker, Kullmann, & Silver, 2004). 
Concentrations of GABA present ambiently and necessitated to activate the extrasynaptic GABAA 
receptor population has been approximated to be in the tens of nanomolar to micromolar range 
(Farrant & Nusser, 2005), upto 0.2- 2.5 μM (Glykys & Mody, 2007). Though various sources have 
been postulated for tonic GABA, it is evident that vescicular release is a crucial determinant of 
tonic GABA presence (Farrant & Nusser, 2005)(Glykys & Mody, 2007), and phasic and tonic 
inhibition mechanisms are elicited with a mutualistic source and relationship. 
2.4.1.3 Presynaptic GABAA receptors  
Recent research has indicated, that counterintuitive to the traditional perspective of post-synaptic 
receptor localization; an extensive range of synaptic receptors are located pre-synaptically. This 
means they are in intimate proximity to neurotransmitter release site and thereby potently impact 
the processes such as fusion of transmitter vesicles. In this manner, GABAARs have also been 
found to be located in the presynapse (Engelman & MacDermott, 2004)(Kullmann et al., 2005b). 
These receptors exert their functions by modulating and influencing neurotransmitter release. Such 
populations of presynaptic GABAARs have been indicated to be located in various encephalic and 
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CNS regions such as the hippocampus, pituitary, and spinal cord. They are even implicated in 
action potential generation and may underpin events of neuropathology (Kullmann et al., 2005b). 
 
2.4.2 GABAB receptors   
 
A structurally divergent class of GABA receptors, GABAB receptors are inhibitory metabotropic 
G-protein coupled receptors (GPCRs). In comparison to GABAARs, they elicit slow and persistent 
forms of inhibition upon GABA binding (Scimemi, 2014). This distinct class of receptors is 
expressed presynaptically and postsynaptically in various neuronal populations, serving discrete 
functions. As GPCRs, they modulate potassium and calcium channel activity, consequently 
eliciting slow post and presynaptic inhibition (Benarroch, 2012)(Waxham, 2013)(Pinard, Seddik, 
& Bettler, 2010). 
In the presynaptic context, these receptors exert their influences by functioning as autoreceptors; 
consequently triggering potassium conductance and waning calcium conductance. In the 
postsynaptic niche, they trigger a distinctively slow inhibitory post synaptic potential, via 
activating potassium currents (Benarroch, 2012)(Pinard et al., 2010). 
This group of receptors are ubiquitous in the several regions of the encephalon and CNS. They 
play diverse roles including modulation of excitation and synaptic plasticity in the neuronal 
populations of the cerebrum and cortex; eliciting rhythmic cortico-thalamic activation; altering 
dopamine function and conveying primary afferent inputs to distal regions such as the brainstem 
and spinal cord (Benarroch, 2012). 
 
2.5. Caged GABA compounds as GABAA receptor agonists and antagonists   
 
Photoactivatable caged GABA compounds have been novel implements for the investigation of 
the vast inhibitory GABAergic networks of the CNS; and the spatiotemporal and kinetic properties 
of the receptors intrinsic to these systems (Rial Verde et al., 2008)(Shi et al., 2014a)(Molnár & 
Nadler, 2000). Caged GABA compounds have a broad scope of applications for neuroscientific 
investigations, which have been addressed and enumerated in various concomitant studies. 
Notable, examples of caged forms of GABA that are more commonly used include CNB-GABA, 
DPNI-GABA, CNI-GABA, CDNI-GABA, Coum-GABA a RuBi-GABA (Molnár & Nadler, 
2000)(Hess et al., 2014)(Ellis-Davies, 2007)(Rial Verde et al., 2008)(Amatrudo et al., 
2014)(Masanori Matsuzaki, Hayama, Kasai, & Ellis-Davies, 2010b)(Richers, Amatrudo, Olson, 
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& Ellis-Davies, 2017)(Fan, Lewis, Hess, & Ganem, 2009)(Shi et al., 2014a)(Jerome & Heck, 
2011)(Kramer et al., 2009)(Amatrudo et al., 2015)(Trigo, Papageorgiou, Corrie, & Ogden, 
2009)(Trigo et al., 2010). A comparison of the most commonly used caged GABA photoactivities 
is illustrated in Table 2.5.1. 
 
 
Table 2.5.1: Most commonly used caged GABA compounds for single photon photolysis have a 
photosensitive covalent bond that is broken by photons with wavelengths corresponding to ultraviolet to 
violet. The sensitivity of RuBi-GABA is extended into longer wavelengths, making it useful for photolysis 
with blue LEDs. Modified from Filevich & Etchenique, 2013.  
 
The spatiotemporal manipulation endowed by these photo-labile tools enables investigations of 
the kinetic properties of GABA receptors, mapping of GABAergic networks, neuronal and 
network related localizing of GABA receptor populations. Synaptic release can be evoked, and 
neuronal populations may be activated or optically silenced. Thus, caged GABA compounds have 
been particularly useful for investigation as a consequence of their role as GABAAR agonists (Rial 
Verde et al., 2008)(Shi et al., 2014a). 
An undesired trait of several caged GABA compounds is their antagonistic actions on GABAARs 
populations when in the unphotolysed precursor form. This imposes a predicament of the ceiling 
concentrations that may be used to elicit quantifiable evoked responses (Richers et al., 2017)(Shi 
et al., 2014a). This is an important to consider as synaptic GABAAR-mediated transmission 
necessitates close to millimolar range local concentration (Farrant & Kaila, 2007; Farrant & 
Nusser, 2005). Caged GABA compounds are usually non-detrimental with respect to pre-
photolytic interactions only at a concentration lower than 200μM (Shi et al., 2014a). 
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Design of caged compounds for GABA receptors must therefore must be propelled with an object 
of optimizing the antagonistic profile of compound and minimizing all such off-target reactions. 
Another sagacious tactic to circumvent these predicaments would be proper quantification of the 
antagonism elicited by these compounds. This would enable us to obtain valid results, and even 
use the antagonistic facet of these compounds in experiments that necessitate such features(Molnár 
& Nadler, 2000)Thus caged GABA compounds serve as both GABAA receptor agonists and 
“inadvertent” antagonists and proper quantification or examination of all their properties would 
enable a comprehensive, validated exploitation of these implements. This would yield accurate 






Ruthenium-bipyridine-triphenylphosphine- GABA, RuBi-GABA, is an inorganic, ruthenium 
based photoactivatable GABA compound (Nikolenko, Yuste, Zayat, Baraldo, & Etchenique, 2005; 
Leonardo  Zayat, Marcelo  Salierno, & Etchenique*, 2006; Zayat, Calero, Alborés, Baraldo, & 
Etchenique, 2003; Zayat et al., 2007)(Rial Verde et al., 2008). It has been employed for 
spatiotemporal investigation of GABAA receptors and GABAergic network populations. RuBi-
GABA has been endorsed for several of its expedient attributes, such as high quantum yield, its 
photo-activation velocity due to the inorganic caging group, and particularly for its photolytic 
properties in the visible light spectrum, enabling GABA uncaging without the need for relatively 
more expensive UV lasers (Rial Verde et al., 2008).The compound is able to produce GABAergic 
responses mimicking endogenous event kinetics, such as rise time kinetics of inhibitory post-
Table 2.5.2 IC50 values of some caged GABA and glutamate compounds, including RuBi-GABA, 
indicating their half maximal concentration of antagonism for GABAAR and stability. From Shi et al., 
2014. 
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synaptic currents (IPSCs) (Rial Verde et al., 2008). With respect to its optical parameters, RuBi-
GABA has an absorption coefficient of εMAX = 5300 M−1 cm−1 at 447 nm and a quantum yield 
of ϕ ∼ 0.09; hence endorsed for its high activity in the arena of caged GABA compounds (Filevich 
& Etchenique, 2013). 
Thus it has been used in studies on receptor kinetic analysis, GABAAR spatiotemporal mapping 
and silencing of neurons (Rial Verde et al., 2008).The consensus based on current literature has 
been that RuBi-GABA antagonizes GABAARs only at millimolar concentrations (Rial Verde; Shi 
et al. 2014). However, no systematic data supporting this claim has been provided (see Rial Verde 
et al. 2008).  
 




Table 2.5.2: Kinetics of GABAAR currents evoked by RuBi-GABA uncaging. From Rial Verde et al., 2008. 




8-dimethylamino hydroxymethyl quinolone (8-DMAQ) caging groups show excellent 
applicability in both one-photon and two-photon set ups, are highly soluble and possess 
expeditious kinetic properties thus making them good candidates for neurotransmitter uncaging in 
electrophysiological experiments. Furthermore, their absorption peaks at a red-shifted spectrum 
making them highly alluring for neuroscientific and biological investigations. They have been used 
previously to cage kainate and glutamate for glutamatergic experiments where they displayed great 
efficacy, especially in comparison to MNI-glutamate(Dunkel et al., 2014)(Tran, Dunkel, Dhimane, 
Ogden, & Dalko, 2016)(Petit et al., 2012). 
The 8-DMAQ caging group has now been utilized in the context of caged GABA, (8-DMAQ-
GABA (Amit Kumar Pundir, Petra Dunkel, Hamid Dhimane, David Ogden, Peter I. Dalko, 
unpublished results), however its GABAAR antagonism profile is unknown.The varients of the 
cage 8-DMAQ were photolysed at 365nm UV and displayed quantum yields of 9.3 and 
6.6%(Dunkel et al., 2014). The molar extinction for 8-DMAQ is εmax=1.5x103(M−1cm−1).  
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3. Aims  
 
The introductory chapters have elucidated the pivotal properties, intrinsic advantages, applicability 
and limitations of caged neurotransmitters and photo-labile GABA compounds; setting a pertinent 
background for the rationale for this study. The primary motivations of the study are to 
comprehend the intrinsic properties of two caged GABA compounds targeting GABAA receptors. 
This study introduces a novel caged GABA compound 8-DMAQ- GABA and aspires to revise the 
intrinsic properties of RuBi-GABA. The primary motivations of this study are: 
1) To examine the GABAAR antagonism profile of a novel caged compound, 8-DMAQ-
GABA, in its caged form, comparing it to that of the widely used RuBi-GABA. 
 
2) To assess whether 8-DMAQ-GABA is useful for mimicking the kinetics of endogenous 
GABAAR-mediated inhibitory post-synaptic currents, IPSCs; while examining the rise 
time kinetics of RuBi-GABA and 8-DMAQ. 
 
3)  To examine the utility of either caged compound at low micromolar concentrations (which 
are least likely to be antagonistic) for inducing photolysis-evoked GABAAR currents. 
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4. Methods and Materials  
 
4.1 Cortical slice preparation  
Postnatal day 16-18 male and female Han Wistar rats were used to obtain coronal brain slices of 
400 micron thickness. Animals were brought from the animal housing 5- 10 minutes prior to 
decapitation to minimize time of maternal separation, and anaesthetized with halothane (2-bromo-
2-chloro-1,1,1-trifluroethane obtained from Sigma Aldrich, St. Louis MO). The depth of 
anaesthesia was verified using tail and toe pinches before decapitation on ice cold sectioning 
solution bubbled with 95% oxygen and 5% carbon dioxide carbogen gas. Following decapitation, 
rapid craniotomy was performed and the brain (with olfactory bulb, brainstem and cerebellum 
dissected out) was removed and placed into the slicing chamber with ice-cold sectioning solution 
(temperature -0.4 to 0 °C). The brain was glued with cyanoacrylate to the vibratome stage and 
coronal slices were cut using a vibrating microtome (7000smz, Campden Instruments, Leicester, 
UK) equipped with a stainless steel blade. The entire sequence of procedures leading up-to the 
slicing were all executed within 3-4 mins after decapitation, and the brain was constantly immersed 
in the ice-cold sectioning solution at all times. 
The entirety of the slicing procedure exposed the brain tissue to sectioning solution temperatures 
below 4°C, where the solution was consistently bubbled with carbogen gas. After each slice was 
obtained from the vibratome it was dissected into two parts (to enable easy placement in the 
recording chamber) and promptly transferred to ACSF standard solution bubbled with carbogen 
and preheated to ~ 34 °C. All of the slices obtained from each brain were recovered in the ACSF 
standard solution, at 34°C with consistent carbogen bubbling (pH 7.4) for a period of 1 hour. 
The solution compositions were as follows: 
Sectioning solution: 87 mM NaCl, 2.5 mM KCl, 0.5 mM CaCl2, 25 mM NaHCO3, 1.25 mM 
NaH2PO4, 7 mM MgSO4, 75 mM sucrose and 25 mM D-glucose. Osmolarity ~ 310 mOsm 
ACSF Standard solution : 124 mM NaCl, 3 mM KCl, 2 mM CaCl2, 25 mM NaHCO3, 1.1 mM 
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4.2 Electrophysiology  
 
Techniques which fall under the vast umbrella of electrophysiology are implemented for various 
forms of neuroscientific investigation. They enable elucidation of functions ranging from minute 
macromolecular machinery to more comprehensive milieus such as network activity. 
Electrophysiological techniques such as the patch-clamp methods can be utilized to monitor and 
comprehend intrinsic electrical properties of neurons, neuronal events and synaptic functions. 
Here, to analyze the antagonistic effects on GABAARs of caged GABA compounds in their caged 
form, whole-cell voltage-clamp was employed to record miniature inhibitory postsynaptic currents 
(mIPSCs), which are an integral current of single GABAAR channel mediated events triggered by 
spontaneous release of a single quanta of GABA into the synaptic cleft. 
 
4.2.1 Whole-cell voltage clamp recordings of mIPSCs  
     
The whole-cell voltage clamp technique has become the most common way of implementing the 
powerful voltage-clamp method in work on mammalian neurons. The less than 5 μm-diameter tip 
of a glass micropipette is gradually brought close the neuronal membrane and a mild suction force 
is applied; creating a tight seal between the membrane and pipette tip. The seal is characterized by 
an electrical resistance of gigaohms and hence referred to as the gigaseal. In this stage, cell-
attached recordings may be obtained. For the whole-cell configuration however, an additional step 
of rupturing the membrane (within the ambit of the micropipette seal) is necessary.  
This rupturing is accomplished by the application of an extremely brief but robust suction pulse, 
which efficaciously eradicates the intra-pipette section of the membrane. The neuron’s cytosolic 
solutions are effectively replaced with the pipette solution within the matter of tens of seconds to 
minutes, thus offering a myriad of opportunities to manipulate the intracellular contents. The goal 
is however, to mostly mimic the intrinsic environment of the neuron’s cytosol, barring a few minor 
alterations to aid the experiment’s objectives (the most common alteration is substitution of cesium 
for potassium in the pipette solution, in order to improve space-clamp, i.e. electrical control of the 
neurons membrane in compartments beyond the spherical soma). In voltage-clamp, membrane 
potential is controlled by currents that are automatically generated by the negative feedback loop 
of the voltage-clamp circuitry, effectively mirroring and canceling out membrane currents, which 
makes the membrane potential follow the “command” potential. In other words the recorded 
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membrane currents are the opposite in polarity to those generated by the amplifier in attempt to 
maintain membrane voltage at the command potential.  
Slices were placed post recovery in the submerged recording chamber, which was consistently 
perfused with ACSF standard solution (composition in previous section). To provide the necessary 
mechanical stability necessary for patch-clamp recordings, the slices were anchored in the chamber 
using a Lycra- threaded stainless steel harp (Warner Instruments, USA). The perfusion rate for the 
recordings was 3.5 ml/minute. In most cases, the ACSF was recycled in baseline recordings for 
economical use of chemicals in long-duration experiments. In the whole-cell recordings of 
mIPSCs, the ASCF extracellular solution also contained TTX (0.5 μM), D-AP5 (20 μM) and 
CNQX (10 μM; all obtained from Tocris) for blocking voltage-gated sodium channels, and 
glutamatergic NMDAR- and AMPAR-mediated currents, respectively. The recording ACSF was 
constantly bubbled with 95% O2/5% CO2 carbogen gas (pH 7.4) and the recording chamber 
temperature was maintained at 32±1 °C.  
Cortical pyramidal neurons were patched using fire polished borosilicate micropipettes with a 
resistance of around 4-6 MΩ, and a cesium-based intracellular/intrapipette solution was used with 
the following composition: 140 mM Cs-methanesulfonate, 2 mM MgCl2, 10 mM Hepes [with pH 
adjusted to 7.2 with CsOH (280 ± 5 mOsm) (Spoljaric et al., 2017)  
For the recording of mIPSCs with the specified solutions, the membrane voltage was clamped at 
0 mV after whole cell configuration was achieved during patching. The liquid junction potential 
generated (with the Cs-based pipette solution) in the first steps of patching was around -13mV 
which was corrected for online. The access resistance was monitored at 120 s intervals throughout 
the recording to ensure that any changes in mIPSC frequency and amplitude were not due to 
voltage clamp deterioration. Only recording with less than 30% change of access resistance were 
processed for further analysis and integrated in the results. 
The mIPSCs generated by GABAARs were recorded and monitored using HEKA Patchmaster 
software and also with Win-EDR (Strathclyde Electrophysiology), with an EPC 10 patch-clamp 
amplifier at a sampling frequency of 50 kHz (HEKA Elektronik, Germany). 
Spontaneous mIPSCs were recorded at 0 mV for at least 5 min in ACSF with blockers before bath 
application of the caged GABA compound (either 5, 10 or 100 μM RuBi-GABA, or 500 μM 
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8-DMAQ). Recordings were continued in the presence of the caged GABA compound for a 
minimum of 10 minutes. As the experiments aspired to elucidate the effects of the caged, 
unphotolysed forms of the caged GABAs and their GABA receptor antagonism, uncaging was not 
performed and all experiments were conducted in darkness. Special precautions were taken with 
RuBi-GABA, which is photolyzed also with visible light, hence all potential sources of light were 
minimized.  
Data were low pass filtered at 1.5 kHz and manually analysed using Mini-Analysis software 
(Synaptosoft). For illustrations, the full-length recordings were high pass filtered at 5.3 Hz 
 
4.2.2 Flash photolysis experiments  
 
Flash photolysis experiments were conducted to compare the rise time kinetics of the GABAAR 
currents evoked by the two caged GABA compounds. To this end, the two caged compounds were 
employed in different concentrations via the ACSF extracellularly and uncaged at the soma of 
pyramidal neuron with a UV laser (372 nm; 2 mW; ~10 µm spot diameter, 0.1 – 10.0 ms flash 
duration). Evoked responses were recorded along with the spontaneously occurring mIPSCs. The 
recordings were then analysed using MiniAnalysis software (Synaptosoft) and the rise-time and 
decay kinetics of the evoked responses were analysed. 
RuBi-GABA was used at the concentration of 5 μM and uncaged with a laser duration of 0.1ms 
after testing at 10 ms and 1 ms laser flashes, which elicited currents much larger in amplitude than 
even the largest mIPSCs. The 5 μM RuBi-GABA with 0.1ms laser duration elicited evoked 
responses that appeared reasonably similar to endogenous mIPSCs. 
8-DMAQ was employed at the concentrations of 1, 5 and 35 μM. For the concentrations of 1 and 
5 μM a laser duration of 10 ms was necessitated to evoke a response a distinguishable from the 
baseline noise. For the 35 μM concentration, a 0.7 ms laser duration was sufficient to see a large 
response. Control experiments were performed to ascertain that the laser stimulation even at 10 
ms flash duration evoked no response in the absence of a cage compound in the bath. 
Gabazine (GABAAR antagonist) application was titrated at 0.2-0.8 µM with all events 
(spontaneous mIPSCs and the RuBi-evoked responses) abolished at 0.6 μM of Gabazine. 
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5. Results  
 
5.1 UV-photolysis of RuBi-GABA and 8-DMAQ-GABA  
 
While RuBi-GABA has been reported to generate uncaging current similar to synaptic GABAARs 
mediated events (Rial Verde et al. 2008), whether the recently synthesized 8-DMAQ-GABA is 
useful for mimicking IPSCs is not known.  
RuBi-GABA uncaged at a 0.1 ms flash duration at the concentration of 5 μM used by Yuste and 
colleagues (Rial Verde et al. 2008), elicited events similar in amplitude to mIPSC, with the rise 
times of the evoked events qualitatively similar to those previously reported by these authors 
(Table 2.1.1 ).  Though having marginally slower rise times, in line with the above previous report, 
these events to some degree, mimicked endogenous mIPSCs (Figure 5.1.3).  
Reproducibly evoked currents with 8-DMAQ-GABA uncaging at a comparable concentration 
(1-5 µM) necessitated increasing the flash duration up-to 10 ms. Event rise times obtained under 
these conditions were comparable. Increasing the concentration of the caged GABA to 35 µM 
permitted decreasing the flash duration to 0.7 ms, while still retaining reproducibility in the 
amplitude of the evoked responses. 
As mentioned in the methods section, 8-DMAQ GABA was used in the concentrations of 1, 5 and 
35 μM. Uncaging was done using 10 ms laser duration for the 1 and 5 μM 8-DMAQ GABA and 
at 35 μM concentration uncaged at 0.7 ms laser duration to achieve a reasonably sized (amplitude-
wise) response.  Typical responses elicited by RuBi-GABA and 8-DMAQ GABA are illustrated 








Figure 5.1.2: (A) Evoked responses elicited by 5 μM RuBi-GABA at 0.1 ms laser durations. The arrow 
indicates the timing of the laser flash of 0.1 ms. The other responses shown in the figure are endogenous 
mIPSCs. Evoked responses elicited by 8-DMAQ GABA at the concentrations 1 μM with 10 ms laser 



















Figure 5.1.3: Comparison of 10-90% rise time of RuBi-GABA evoked responses (5 μM uncaged with 
0.1 ms laser duration) to that of endogenous mIPSCs. Values used were the mean 10-90 rise time and slope 
(for endogenous mIPSCs and the evoked response and t-tests were used for statistical analysis. Double 
asterisks indicates p < 0.005. Here the p value for rise times was 0.0018. The slope values did not display 
statistically significant difference between the two groups. n=6 for evoked responses and a total of 29 
mIPSC events. 
 
The evoked responses elicited by 8-DMAQ GABA were much slower with respect to rise time 
kinetics (when compared to endogenous events and also RuBi-elicited responses). 8-DMAQ 
GABA evoked responses did not display (as indicated in Figure 5.1.2) the distinctive “sharp” rise 
seen in mIPSCs (symptomatic of fast rise times and high slope values), even to the degree of RuBi-
GABA.  
The 10-90% rise time and 10-90% slope of the 8-DMAQ GABA elicited events were analyzed 
and compared with the endogenous mIPSCs of each recording, revealing that the 8-DMAQ evoked 








Figure 5.1.4: Comparison of 10-90% (A) rise time and 10-90% slope (B) of 8-DMAQ GABA elicited 
responses and endogenous mIPSCs. Values used were the mean 10-90 rise time and slope in each case (for 
the evoked response and mIPSCs) and post hoc Anova analysis was used for statistical analysis. Here, an 
asterisk indicates p <0.05, two indicate p <0.005 three asterisks indicate a significance of p <0.0005. n= 5-6 
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5.2. GABAA receptor antagonism by micromolar RuBi-GABA  
RuBi-GABA effectively abolishes mIPSCs at 100 μM 
Cortical pyramidal neurons were patched and after recording the baseline with spontaneous 
mIPSCs for a minimum of 5 minutes; RuBi-GABA was applied via the extracellular solution 
(ACSF) perfusion system for a minimum of 10 minutes (see Methods and Materials, voltage 
clamp). Access resistance was constantly monitored to ensure that any changes in mIPSC 
frequency and amplitude were not due to access resistance change. In a surprising manner, RuBi-
GABA consistently and almost completely abolished mIPSCs, dramatically reducing both the 
amplitude and frequency of mIPSCs (Figures 5.2.1; 5.2.4).  
 
Figure 5.2.1:  RuBi-GABA effectively abolishes mIPSCs at 100 μM concentration. This is indicative of 
severe GABAAR antagonism. Upper trace depicting baseline mIPSCs and their amplitudes after RuBi-
GABA application in a contracted time scale. The transient full-amplitude deflections that are seen with a 
constant interval in the top trace are caused by access resistance monitoring. The inset lower traces depict 
basline mIPSCs and mIPSCs post RuBi-GABA application in an expanded time scale. *Test pulse current 
transients elicited every two minutes to monitor access resistance were truncated. 
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RuBi-GABA exerts marked GABAAR antagonistic effects at low micromolar concentrations 
Motivated by the striking antagonistic effect achieved RuBi-GABA at 100 µM we next sought to 
examine whether this effect extends to the low micromolar concentrations 5-10 µM, that have been 
used in patch clamp experiments (e.g. Chamma et al. 2013 JNS), and reported not to impart 
GABAAR antagonism (Rial Verde et al. 2008). Contrary to this report, under the present 
conditions, RuBi GABA, both at 5 (Figures 5.2.2) and 10 μM (Figure 5.2.3) RuBi-GABA 
continued to significantly suppress both the amplitude and frequency of mIPSCs in a dose 
dependent manner (Figure 5.2.4).  
 
Figure 5.2.2: RuBi-GABA has a marked antagonistic effect even at 10 μM concentration. Upper trace 
depicting baseline mIPSCs and their amplitudes after RuBi-GABA application. The transient full-amplitude 
deflections that are seen with a constant interval in the top trace are caused by access resistance monitoring. 
The inset lower traces depict baseline mIPSCs and mIPSCs post RuBi-GABA application in an expanded 
time scale. The markedly diminished amplitude and frequency are visible in all traces. *Test pulse current 
transients elicited every two minutes to monitor access resistance were truncated. 
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Figure 5.2.3: RuBi-GABA antagonism persists and is distinguishable at 5 μM concentration. Upper trace 
depicting baseline mIPSCs and their amplitudes after RuBi-GABA application .The transient full-amplitude 
deflections that are seen with a constant interval in the top trace are caused by access resistance monitoring. 
The inset lower traces depict baseline mIPSCs and mIPSCs post RuBi-GABA application in an expanded 
time scale. The GABAAR antagonism posed by RuBi-GABA is evidently distinguishable in all traces even 
at such a low concentration. *Test pulse current transients elicited every two minutes to monitor access 
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5.3 GABAA receptor antagonism profile of 8-DMAQ-GABA 
8-DMAQ-GABA does not display GABAAR antagonism even at 500 μM 
The novel caged GABA compound 8-DMAQ GABA (provided by Dr. Peter Dalko, Paris 
Descartes University) was employed to examine its possible antagonistic actions on GABAARs 
and the mIPSCs mediated by the receptors. Based on previous pilot experiments on spontaneous 
IPSCs (TTX-free recording conditions ) in our laboratory this compound was presently used at a 
concentration of 500 μM and similar experiments were conducted in darkness, where the caged 8-
DMAQ GABA was applied for a minimum of 10 minute after a 5 minute baseline recording. The 
caged compound was applied via the extracellular ACSF perfusion. 
The novel caged GABA 8-DMAQ did not have any antagonistic actions nor did it diminish 
mIPSCs (Figure 5.3.1), even at the high concentration of 500 μM. (Here too, access resistance was 




Figure 5.2.4: The effect of RuBi-GABA on mIPSC frequencies and amplitudes. All numbers were 
normalized with the baseline values. n = 3 to 4 recorded neurons for each RuBi-GABA concentration 
and a total of 10 baseline controls. Statistical significance was observed in each case (paired t test with 
post hoc mixed-effects analysis); ***p < 0.0001. 
 




Figure 5.3.1: 8-DMAQ GABA does not display GABAAR antagonism even at 500 μM. Upper trace 
depicting baseline mIPSCs and their amplitudes after 8-DMAQ-GABA application scale. The transient full-
amplitude deflections that are seen with a constant interval in the top trace are caused by access resistance 
monitoring. The inset lower traces depict baseline mIPSCs and mIPSCs post 8-DMAQ-GABA application 
in an expanded time scale. The absence of antagonism is evident in all the traces depicting undiminished 
mIPSC frequency and amplitudes. *Test pulse current transients elicited every two minutes to monitor 
access resistance were truncated. 
 
Further analysis of parameters such as mIPSC frequency and amplitudes revealed a statistically 
significant trend where there was no GABAAR antagonism posed by 8-DMAQ. Paradoxically, this 
compound has a positive modulatory effect on both mIPSC frequencies and amplitudes (Figure 
5.3.2). Paired and unpaired t-tests were used for both these parameters (amplitude and frequency) 
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Figure 5.3.2: The effect of 8-DMAQ GABA at 500 μM on mIPSC frequencies and amplitudes. All numbers 
were normalized with the baseline values. n=6 for 8-DMAQ experiments with 6 controls. Statistical 
significance was observed in each case (paired and unpaired t-tests were the statistical measures employed 
here p values: for frequencies = 0.0325 * and amplitudes = 0.0042 **). This clearly indicates the positive 
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6. Discussion 
One of the primary objectives of this study was to, using electrophysiological experiments, 
establish an antagonism profile for RuBi-GABA by observing its effects on mIPSCs in its caged 
form when applied extracellularly. No systematic assessment of the GABAA receptor antagonism 
profile of RuBi-GABA is provided in the existing literature. Rial Verde and colleagues (2008) 
reported that RuBi-GABA does not display GABAAR antagonism in the low micromolar range: 
“at concentrations<20μM we have never detected any effect on either membrane resistance, or 
frequency or amplitudes of mEPSCs or mIPSCs (Rial Verde et al., 2008)”. This is especially 
problematic as this compound is currently one of the most widely used caged GABA compounds. 
Furthermore, papers describing the antagonistic actions of other caged GABAs appear to describe 
very different numbers, for example, micromolar concentrations typically employed for uncaging 
are able to antagonize GABAARs (Molnár & Nadler, 2000).  
The aim furthermore was to determine the lowest concentrations at which the compound poses 
GABAAR antagonism. This preponderantly used caged GABA has been reported thus far to elicit 
significant GABAAR antagonism only in the millimolar concentration  range (Rial Verde et al., 
2008). There are therefore no publications explicitly affirming the exact antagonism profile with 
realistic values. The major discovery of this study is that this caged compound poses severe 
GABAAR antagonism already at low micromolar concentrations. At 100 μM, RuBi-GABA 
abolishes mIPSCs and at 10 μM causes a marked diminishment of mIPSC frequencies and 
amplitudes. Even at a very low concentration of 5 μM, GABAAR antagonism elicited by RuBi-
GABA persists and is distinguishable. These values from the results of this thesis are similar to 
values described for the antagonism elicited by other caged GABA forms, for example, cGABA 
(Molnár & Nadler, 2000).  
As discussed in the introductory chapters, an ideal caged compound must not have any interactions 
with the biological system in its unphotolysed form, and neither should non-target by-products 
elicit any biochemical alterations. However, many caged compounds do have inadvertent 
biological activity in their unphotolysed form, and a multitude of caged neurotransmitters act as 
receptor antagonists in the caged form (Adams & Tsien, 1993; Amatrudo et al., 2015; G. C. R. 
Ellis-Davies, 2007; A. Gurney, 2008; Hess et al., 2014; Jerome & Heck, 2011; J H Kaplan & 
Somlyo, 1989; Mayer & Heckel, 2006; Richers et al., 2017). 
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Hence, the synthesis and design of caged compounds must be primarily propelled by the objective 
minimizing all off-target reactions and biochemical alterations. The antagonism profile must be 
optimized if not negated in the case of photo activated neurotransmitters. Furthermore, a sagacious 
approach would be to properly quantify the antagonism profile and its various interactions with 
the biological system if at all they are inevitable. Proper quantification of such effects such as 
antagonism would enable valid results and accurate experimental methodology. Moreover, 
apposite and exhaustive comprehension of the compounds properties would allow us to exploit all 
facets of their activity. For example, even the antagonistic properties of such compounds can be 
exploited in experimental procedures that necessitate such elements (Molnár & Nadler, 2000). All 
in all, this would yield valid empirical results. Thus, this study has increased our knowledge on 
the properties of the caged GABA compound RuBi-GABA, by revising its antagonism profile. 
The study was also impelled by the objective of understanding the antagonism profile of the novel 
caged GABA compound 8-DMAQ-GABA in its unphotolysed form. The results of this study 
revealed that this compound does not pose significant antagonistic effects on GABAAR activity 
even at a remarkably high concentration as 500 μM. In fact, in the present experiments a small but 
statistically significant degree of positive modulation, where mIPSC frequencies and amplitudes 
were consistently increased. A parsimonious explanation to such an effect is that part of 8-DMAQ-
GABA had spontaneously degraded into free GABA or been photolyzed by exposure to a light 
source. The latter option is effectively excluded as care was taken to maintain the both the dry 
stock and aliquots of the compound in darkness even during the experiments, which were 
conducted under a dim infrared light directed away from the patch setup. The exact mechanism of 
this positive modulation is beyond the ambit of this study and requires further scrutiny using mass 
spectrometry to assess whether spontaneous degradation releasing free GABA has occurred in the 
stock solution. Of note, in a pilot experiment conducted earlier this year, no positive modulation 
by 500 µM 8-DMAQ-GABA was observed (M. Puskarjov, unpublished observation). 
Furthermore, single channel activity of GABAARs could be monitored with this compound to 
delve further into the kinetics and intricacies of this positive modulation. 
Since 8-DMAQ does not antagonize GABAARs as indicated by this study, this photolabile 
implement could serve to be particularly useful (once the underlying mechanism of positive 
modulation is illumined). 8-DMAQ may be used in very high concentrations to mimic synaptic 
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cleft neurotransmitter concentrations; which is otherwise unachievable with alternative caged 
GABA forms. This is because their high GABA receptor antagonism levies a ceiling concentration 
limit, which is significantly lower than cleft concentrations. Hence, 8-DMAQ GABA shows 
substantial promise as a novel candidate in this arena.  
Reaction kinetics of evoked responses by both the caged GABAs were also examined in this study 
to understand their properties of photolysis. The study clearly revealed that RuBi-GABA is able 
to elicit evoked responses that mimic endogenous mIPSCs to a degree, displaying the characteristic 
“sharp” rise of endogenous mIPSCs. Though a bit slower than endogenous mIPSCs with respect 
to rise times (10-90% rise time), RuBi-GABA appears to be a great candidate for mimicking 
spontaneous events, as endorsed by previous literature (Amatrudo et al., 2015) (Rial Verde et al., 
2008). Furthermore, these rise kinetics can be optimized by simple methodological improvements 
by altering the location of uncaging along the neurons, for example, to elicit fast responses closely 
mimicking mIPSCs (Rial Verde et al., 2008). RuBi-GABA is able to produce reliable evoked 
responses at low concentrations such as 5 μM, necessitating very brief laser flashes (0.1 ms for 
this concentration under the present experimental conditions) to produce events with the 
amplitudes of endogenous mIPSCs. Such attributes are ideal for minimizing any photo damage to 
the cell. 
Currents evoked by 8-DMAQ-GABA uncaging on the other hand, display much slower rise time 
kinetics than RuBi-GABA, (as seen with the 10-90% rise time and slope), producing evoked 
responses that do not exhibit the characteristic sharp rise of mIPSCs. The rise time and slope 
parameters of the evoke responses by 8-DMAQ also differ from those of endogenous mIPSCs. 
Thus this compound is perhaps not applicable for eliciting evoked responses closely imitating 
spontaneous events. The compound also requires a laser flash duration longer than necessitated by 
RuBi-GABA (10 ms laser flash for an evoked response with an amplitude response that was close 
to that of the mIPSC at 5 μM concentration). This attribute of 8-DMAQ GABA is conceivably a 
corollary of unspecific absorption (Trigo et al., 2009), thus necessitating optimization. This 
compound is able to produce evoked responses at concentrations as low as 1 μM, and also reliably 
responds to laser flashes (consistent uncaging with respect to timing of flash), as does RuBi-
GABA. 
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The slow rise times of 8-DMAQ are possibly indicative of the velocity of the dark reactions that 
occur after the photon has impacted the bond triggering photolysis; which in 8-DMAQ’s case 
possibly proceed slowly. 
In this study, the lowest concentration of RuBi-GABA employed was 5 μM for uncaging 
responses, which necessitated only a 0.1 ms flash (longer flashes elicited responses of huge 
amplitudes in comparison to mIPSCs). This indicates that the compound may be used at much 
lower micromolar concentrations (by calibrating laser duration appropriately) for uncaging 
experiments. 8-DMAQ was also able to produce evoked events at 1 μM concentration with a 10 
ms flash, however mIPSC level amplitudes were only obtained with a 5 μM concentration. These 
results provide clues about lowest useful concentrations that may be implemented in the case of 
each compound for uncaging experiments. The fact that in the present experiments GABAAR 
currents could be evoked by uncaging GABA from cage concentrations as low as 1 µM strongly 
indicate that such currents are mediated by extrasynaptic high-affinity GABAARs. This is an 
interesting conclusion, as typically, as done also presently, kinetics of uncaging evoked responses 
are compared to synaptic mIPSCs or sIPSC, which are mediated by synaptic GABAARs. On the 
other hand both mIPSCs and currents evoked from 5 µM caged GABA were equally blocked by 
sub micromolar concentrations of Gabazine, which are known to preferentially target synaptic 
GABAARs. This suggests that at the concentrations typically used for uncaging >5 µM (Puskarjov 
2017 Anesthesiology; Chamma et al. 2013 JNS, Real Verde et al. 2008) the evoked events are 
mediated by a mixture of both tonic and phasic GABAARs.   
In conclusion, the revised antagonism profile for RuBi-GABA yielded by this study illumine the 
intrinsic properties, limitations and novel applications of this caged compound. This experimental 
thesis also scrutinized the photo-kinetic profile of this compound, emphasizing its robust attribute 
that may be used to mimic endogenous events.  The visible-light absorption of RuBi- GABA is its 
endorsed asset; however, as is evident from the literature (cite here the review with the wavelengths 
table) and shown also in study shows that photolysis of the compound is possible with a UV- range 
light source.  
The novel compound 8-DMAQ shows promise as a caged GABA candidate due to the absence of 
any GABAAR antagonism. Hence, the compound may be used in very high concentrations to 
specifically target synaptic populations and also mimic cleft concentrations. However, it does 
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exhibit a surprising trait of positively modulating GABAAR activity, which requires further 
scrutiny. The study revealed its comparably slower photolysis and kinetics, an attribute which may 
levy certain limitations. If the minute intricacies of kinetics are not very important to an 
experimental methodology, 8-DMAQ is a good candidate to provide reliable uncaging responses. 
This caged compound is also not sensitive to visible light, thus reliable for uncaging without 
spontaneous or non-specific photolysis via any ambient light source or stray photons (whereas 
RuBi-GABA requires a dark setting for reliable uncaging). 
Thus, this study elucidates certain intrinsic properties of two forms of caged GABA, augmenting 
the perspectives on their applications and future directions for these persuasive implements. 
Evidently both RuBi-GABA and 8-DMAQ possess their inherent merits and also some 
inadequacies. The choices made with respect to such apparatuses always depends on the requisites 
of the experimental system and the queries that are pursued. The results of this study clearly 
demarcate a few aspects concomitant to RuBi-GABA and the novel contender 8-DMAQ; however 
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